Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically Ill Hospitalized Patients With COVID-19
Type
Journal articlePermalink
https://hdl.handle.net/10161/24220Published Version (Please cite this version)
10.1001/jama.2021.23605Publication Info
Berger, Jeffrey S; Kornblith, Lucy Z; Gong, Michelle N; Reynolds, Harmony R; Cushman,
Mary; Cheng, Yu; ... ACTIV-4a Investigators (2022). Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non–Critically
Ill Hospitalized Patients With COVID-19. JAMA, 327(3). pp. 227-227. 10.1001/jama.2021.23605. Retrieved from https://hdl.handle.net/10161/24220.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Renato Delascio Lopes
Professor of Medicine
Atrial Fibrillation Antithrombotic Therapy in patients with Acute Coronary Syndromes
Elderly patients with Heart Disease Biomarkers in Acute Coronary Syndromes and Atrial
Fibrillation Thrombosis and Anticoagulation and novel antithrombotic agents Metabolomics
in Cardiovascular Medicine
Lana Wahid
Medical Instructor in the Department of Medicine
Clinical researcher, trialist, hospitalist and educator.
Alphabetical list of authors with Scholars@Duke profiles.

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info